|
|
Candela Corporation (NASDAQ: CLZR) announced today that it has established a Scientific Advisory Board, and that the newly established Board will be chaired by Dr. Eric F. Bernstein. Dr. Bernstein has relinquished his role on the Company's Board of Directors, effective August 28, 2006.
Gerard E. Puorro, Candela's President and Chief Executive Officer, said: "We today have approximately thirty clinical studies underway in various locations around the world. The establishment of a Scientific Advisory Board will bring additional oversight and further streamline our processes for clinical research." Puorro continued: We are quite fortunate to have Dr. Bernstein agree to accept this role. His background, experience and intellectual integrity are unsurpassed in our industry."
Commenting on his acceptance of this new position, Dr. Bernstein said: "Candela has always been a leader in laser technology, and I hope to contribute both scientifically and through my clinical relationships to the continued development of innovative products to benefit our patients."
About CANDELA: Candela Corporation manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, the company markets and services its products in over 70 countries from offices and distributors in the United States, Europe, Japan, China and other Asian locations. Candela established the aesthetic laser market 17 years ago, and currently has an installed base of 9,000 lasers worldwide. Candela is an Equal Opportunity and Affirmative Action Employer (Male/Female/Handicapped/Veteran). Visit Candela on the Web at http://www.candelalaser.com
No comments:
Post a Comment